NANOVIRICIDES, INC. Interest Expense Nonoperating
NANOVIRICIDES, INC. (NNVC) reported Interest Expense Nonoperating of $149 for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-05-15
- NANOVIRICIDES, INC. interest expense nonoperating for the quarter ending 2025-06-30 was $0.00.
- NANOVIRICIDES, INC. interest expense nonoperating for the quarter ending 2025-03-31 was $0.00.
- NANOVIRICIDES, INC. interest expense nonoperating for the quarter ending 2024-12-31 was $149.00, a 98.88% decline year-over-year.
- NANOVIRICIDES, INC. interest expense nonoperating for the quarter ending 2024-06-30 was $0.00.
- NANOVIRICIDES, INC. interest expense nonoperating for fiscal 2025 was $149.00, a 99.70% decline from fiscal 2024.
- NANOVIRICIDES, INC. interest expense nonoperating for fiscal 2024 was $49.81K, a 5210.02% increase from fiscal 2023.
- NANOVIRICIDES, INC. interest expense nonoperating for fiscal 2023 was $938.00.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $149.00 derived: sum of 3 quarters · filed 2026-05-15 | $149.00 10-K · filed 2025-09-29 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $149.00 derived: sum of 2 quarters · filed 2026-05-15 | $149.00 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $149.00 10-Q · filed 2026-02-17 | $149.00 10-Q · filed 2026-02-17 | ||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $0.00 derived: sum of 2 quarters · filed 2025-09-29 | $13.31K derived: sum of 3 quarters · filed 2025-09-29 | $49.81K 10-K · filed 2025-09-29 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $13.31K derived: sum of 2 quarters · filed 2025-05-15 | $49.81K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $13.31K 10-Q · filed 2025-02-14 | $49.81K 10-Q · filed 2025-02-14 | ||
| 2023-09-30 | $36.49K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $938.00 10-K · filed 2024-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |